Hollow Brook Wealth Management’s Pfizer PFE Stock Holding History

Hollow Brook Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.74M	Buy	196,805 +26,434	+16%	+$691K	0.94%	23
2026 Q1	$4.78M	Sell	170,371 -3,781	-2%	-$101K	1.22%	22
2025 Q4	$4.34M	Buy	174,152 +34,001	+24%	+$857K	1.12%	25
2025 Q3	$3.57M	Buy	140,151 +7,797	+6%	+$192K	0.84%	31
2025 Q2	$3.21M	Sell	132,354 -1,893	-1%	-$44.1K	0.93%	31
2025 Q1	$3.4M	Sell	134,247 -5,849	-4%	-$153K	1%	29
2024 Q4	$3.72M	Buy	140,096 +73,494	+110%	+$1.99M	1.14%	29
2024 Q3	$1.93M	Buy	66,602 +3,137	+5%	+$91.5K	0.57%	47
2024 Q2	$1.78M	Buy	63,465 +3,776	+6%	+$104K	0.6%	45
2024 Q1	$1.66M	Buy	59,689 +1,363	+2%	+$37.8K	0.61%	42
2023 Q4	$1.68M	Buy	58,326 +13,041	+29%	+$394K	0.67%	43
2023 Q3	$1.5M	Buy	45,285 +37,215	+461%	+$1.32M	0.63%	44
2023 Q2	$296K	Sell	8,070 -190	-2%	-$7.39K	0.13%	72
2023 Q1	$337K	Hold	8,260	–	–	0.16%	63
2022 Q4	$423K	Sell	8,260 -1,440	-15%	-$69K	0.2%	60
2022 Q3	$424K	Sell	9,700 -23	-0.2%	-$1.12K	0.24%	53
2022 Q2	$510K	Sell	9,723 -4,376	-31%	-$223K	0.28%	51
2022 Q1	$730K	Hold	14,099	–	–	0.33%	50
2021 Q4	$833K	Buy	14,099 +2,291	+19%	+$114K	0.43%	49
2021 Q3	$508K	Hold	11,808	–	–	0.31%	50
2021 Q2	$462K	Hold	11,808	–	–	0.29%	44
2021 Q1	$428K	Sell	11,808 -344	-3%	-$12.2K	0.28%	39
2020 Q4	$447K	Sell	12,152 -1,852	-13%	-$67.9K	0.27%	36
2020 Q3	$488K	Buy	14,004 +1,260	+10%	+$44.2K	0.3%	33
2020 Q2	$395K	Hold	12,744	–	–	0.3%	34
2020 Q1	$395K	Sell	12,744 -179	-1%	-$6.1K	0.37%	29
2019 Q4	$480K	Buy	12,923 +179	+1%	+$6.38K	0.25%	40
2019 Q3	$434K	Hold	12,744	–	–	0.29%	40
2019 Q2	$524K	Buy	12,744 +369	+3%	+$14.7K	0.48%	35
2019 Q1	$499K	Hold	12,375	–	–	0.54%	34
2018 Q4	$512K	Hold	12,375	–	–	0.55%	34
2018 Q3	$517K	Hold	12,375	–	–	0.4%	42
2018 Q2	$426K	Hold	12,375	–	–	0.34%	47
2018 Q1	$417K	Hold	12,375	–	–	0.33%	40
2017 Q4	$425K	Hold	12,375	–	–	0.31%	36
2017 Q3	$419K	Hold	12,375	–	–	0.31%	36
2017 Q2	$394K	Sell	12,375 -147,024	-92%	-$4.64M	0.27%	36
2017 Q1	$5.17M	Sell	159,399 -181,899	-53%	-$5.74M	4.03%	10
2016 Q4	$10.5M	Sell	341,298 -3,230	-0.9%	-$98.6K	6.5%	5
2016 Q3	$11.1M	Buy	344,528 +21,952	+7%	+$734K	6.54%	5
2016 Q2	$10.8M	Sell	322,576 -42,580	-12%	-$1.36M	7.46%	4
2016 Q1	$10.3M	Sell	365,156 -45,302	-11%	-$1.29M	6.12%	6
2015 Q4	$12.6M	Sell	410,458 -26,791	-6%	-$843K	6.24%	5
2015 Q3	$13M	Sell	437,249 -1,334	-0.3%	-$42.8K	6.22%	4
2015 Q2	$14M	Sell	438,583 -33,937	-7%	-$1.11M	5.34%	6
2015 Q1	$15.6M	Sell	472,520 -30,778	-6%	-$979K	5.18%	6
2014 Q4	$14.9M	Buy	503,298 +108,196	+27%	+$3.1M	4.82%	8
2014 Q3	$11.1M	Buy	395,102 +24,622	+7%	+$691K	3.63%	10
2014 Q2	$10.4M	Buy	370,480 +6,144	+2%	+$175K	3.55%	10
2014 Q1	$11.1M	Sell	364,336 -6,157	-2%	-$184K	3.63%	8
2013 Q4	$10.8M	Sell	370,493 -3,072	-0.8%	-$89.4K	3.53%	10
2013 Q3	$10.2M	Sell	373,565 -105,071	-22%	-$2.86M	3.56%	8
2013 Q2	$12.7M	Buy	+478,636	New	+$13.2M	4.69%	4

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hollow Brook Wealth Management's PFE Position: Q2 2026 in Review

Hollow Brook Wealth Management increased its Pfizer (PFE) stake by 16% in Q2 2026, buying an estimated $691K and bringing the position to 196,805 shares worth $4.74M. The position accounts for 0.94% of the portfolio, ranked #23.

Hollow Brook Wealth Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.6M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Hollow Brook Wealth Management held 196,805 shares of Pfizer worth $4.74M as of Q2 2026.
Hollow Brook Wealth Management bought 26,434 Pfizer shares in Q2 2026, an estimated $691K.
Pfizer made up 0.94% of Hollow Brook Wealth Management's portfolio in Q2 2026, its #23 holding.
Hollow Brook Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Hollow Brook Wealth Management's Pfizer position peaked at $15.6M in Q1 2015.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hollow Brook Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.